Mol Med Rep:螺旋藻-姜黄素-波斯菊能有效地减少良性甲状腺结节的大小

2020-08-05 MedSci原创 MedSci原创

良性甲状腺结节是最常见的内分泌疾病之一。影像学和病理学诊断的最新进展极大地促进了甲状腺结节风险分层的改善。然而,除了手术方法外,目前的治疗方案是有限的。以下研究首次介绍了一种非侵入性疗法治疗良性甲状腺

良性甲状腺结节是最常见的内分泌疾病之一。影像学和病理学诊断的最新进展极大地促进了甲状腺结节风险分层的改善。然而,除了手术方法外,目前的治疗方案是有限的。以下研究首次介绍了一种非侵入性疗法治疗良性甲状腺结节的结果。

 

该研究为一项为双盲、安慰剂对照研究,为期3个月,评估了含有螺旋藻、姜黄素和波斯菊的补充剂对良性甲状腺结节的甲状腺患者的疗效和安全性,该研究由34名患者完成。在一项前瞻性安慰剂对照交叉试验中,评估了2至5厘米之间的良性(FNAB记录)单个甲状腺结节患者,横跨12周(3次访问,间隔6周)。在每次访问中,对目标甲状腺结节进行二维记录。此外,研究人员还评估了甲状腺刺激素、游离甲状腺素和铜的血浆水平。

 

结果显示,V1处的平均初始结节面积为4.38±3.14cm2,V2处为3.87±2.79cm2,V3处为3.53±2.84cm2;P<0.04。给予活性物质(n=34)后,平均面积减少0.611 cm2±0.933(SD),而服用安慰剂(n=29)后,平均面积减少0.178 cm2±0.515(SD),(P=0.027)。

 

综上所述,该研究结果表明,螺旋藻-姜黄素-波斯菊的组合能有效地减少良性甲状腺结节的大小。然而,还需要进行更多的研究以阐明所建议的补充剂促进甲状腺良性结节大小缩小的确切机制。

 

原始出处:

 

Felician StancioiuDaniel Mihai, et al., Treatment for benign thyroid nodules with a combination of natural extracts. Mol Med Rep. 2019 Sep;20(3):2332-2338. doi: 10.3892/mmr.2019.10453. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1967079, encodeId=6540196e0798f, content=<a href='/topic/show?id=975988893b6' target=_blank style='color:#2F92EE;'>#螺旋藻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88893, encryptionId=975988893b6, topicName=螺旋藻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Oct 27 18:03:57 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610639, encodeId=ed3e1610639ee, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 07 06:03:57 CST 2020, time=2020-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806514, encodeId=e58580651499, content=可以试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aefd2480015, createdName=洋葱花, createdTime=Thu Aug 06 13:01:53 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806318, encodeId=fc4180631826, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Wed Aug 05 15:15:39 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1967079, encodeId=6540196e0798f, content=<a href='/topic/show?id=975988893b6' target=_blank style='color:#2F92EE;'>#螺旋藻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88893, encryptionId=975988893b6, topicName=螺旋藻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Oct 27 18:03:57 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610639, encodeId=ed3e1610639ee, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 07 06:03:57 CST 2020, time=2020-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806514, encodeId=e58580651499, content=可以试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aefd2480015, createdName=洋葱花, createdTime=Thu Aug 06 13:01:53 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806318, encodeId=fc4180631826, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Wed Aug 05 15:15:39 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1967079, encodeId=6540196e0798f, content=<a href='/topic/show?id=975988893b6' target=_blank style='color:#2F92EE;'>#螺旋藻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88893, encryptionId=975988893b6, topicName=螺旋藻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Oct 27 18:03:57 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610639, encodeId=ed3e1610639ee, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 07 06:03:57 CST 2020, time=2020-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806514, encodeId=e58580651499, content=可以试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aefd2480015, createdName=洋葱花, createdTime=Thu Aug 06 13:01:53 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806318, encodeId=fc4180631826, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Wed Aug 05 15:15:39 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
    2020-08-06 洋葱花

    可以试试

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1967079, encodeId=6540196e0798f, content=<a href='/topic/show?id=975988893b6' target=_blank style='color:#2F92EE;'>#螺旋藻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88893, encryptionId=975988893b6, topicName=螺旋藻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Oct 27 18:03:57 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610639, encodeId=ed3e1610639ee, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 07 06:03:57 CST 2020, time=2020-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806514, encodeId=e58580651499, content=可以试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aefd2480015, createdName=洋葱花, createdTime=Thu Aug 06 13:01:53 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806318, encodeId=fc4180631826, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Wed Aug 05 15:15:39 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
    2020-08-05 ms3000000449926787

    学习了

    0

相关资讯

甲状腺结节TI-RADS分级解读

TI-RADS(Thyroid imaging reporting and data system)即甲状腺影像报告和数据系统。依据五个甲状腺结节恶性特征进行分级:1、实性结节;2、低回声或极低回声;

Mol Med Rep:螺旋藻-姜黄素-波斯菊治疗良性甲状腺结节的效果

良性甲状腺结节是最常见的内分泌疾病之一,影像学和病理学诊断的最新进展极大地促进了甲状腺结节风险分层的改善。然而,除了手术方法外,目前的治疗方案是有限的。本研究为一项为期3个月的双盲、安慰剂对照研究,评

石墨烯又一重磅研究:助力甲状腺结节治疗,拓展临床新应用

石墨烯被誉为“新材料之王”,是目前发现的最薄、强度最大、导电导热性能最强的一种新型纳米材料,是一种由碳原子以sp2杂化方式形成的蜂窝状平面薄膜,具备优良的电学、热学及光学等性能,不仅在涂料、发热散热、供暖、触控等领域实现初步应用,在医疗领域也被视为引发下一次医疗革命的关键。石墨烯治疗“甲状腺结节”重大医疗突破4月28日,由烯旺新材料科技股份有限公司(以下简称:烯旺科技)主办的医疗战略研讨会暨新品发

甲状腺结节是良性还是恶性?问5个问题就能搞清!

2万个甲状腺结节总结出的经验,5个问题搞定结节良恶性!

甲状腺结节微波消融手术的常见问题解答

甲状腺结节是指甲状腺内出现的一个或多个结构异常团块。大多数甲状腺结节患者没有临床症状,常常是由本人无意中发现或医生在体检时触及,更多情况下是在超声或其它辅助检查时偶然被发现。根据2010年中国流行病学抽样调查,甲状腺结节在人群中总发病率为18.6%。如此庞大的数字并不仅仅源自疾病发病率的升高,更多还是归因于人们对健康的重视和体检的普及,特别是甲状腺超声等检查被列为健康体检的常规项目。使得以前“躲在

Thyroid:二甲双胍在治疗甲状腺结节和胰岛素抵抗患者中的作用

由此可见,二甲双胍可诱导甲状腺结节和胰岛素抵抗患者甲状腺结节缩小和TSH、HOMA-IR水平降低。相反,未发现甲状腺体积变化。二甲双胍治疗甲状腺结节是否具有临床意义仍有待证实。